choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Complera

Complera Newsletter
  • A Student Pharmacist’s Guide to HIV Medications 23 May 2025 17:23 GMT

    … is HIV/AIDS? HIV attacks … drug combinations include Odefsey (rilpivirine/emtricitabine/tenofovir alafenamide fumarate), Complera … combined with statin medications such … choosing-hiv-treatment-regimen 4. HIV treatment: FDA-approved HIV medicines. …

  • Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors 30 Apr 2025 14:37 GMT

    pharmaceutical company that allegedly paid doctors kickbacks to push their HIV/AIDS drugs … in Medicare, Medicaid, and TRICARE payments. The Gilead HIV antiretroviral drugs are … Complera®, for example. From 2011 to November 2017, the company conducted HIV

  • Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions 29 Apr 2025 21:59 GMT

    … s drugs, which include Biktarvy, Descovy, Stribild, Genvoya, Complera, and … prescriptions." One doctor who spoke at Gilead … HIV drugs that resulted in upward of $6 million in Medicare, Medicaid … have transformed the treatment paradigm for HIV, and Gilead …

  • Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks 29 Apr 2025 19:17 GMT

    Medicare, Medicaid and other programs into paying for drugs prescribed by doctors … approximately 384 dinners. The HIV drugs included Biktarvy, Complera, Descovy, Genvoya, … doctor who treats patients diagnosed with HIV/AIDS. Gilead’s HIV drug sales …

  • ESCMID Global 2025: Global access issues remain for long-acting HIV injectables 22 Apr 2025 20:49 GMT

    pills are now commonly used, consolidating multiple active pharmaceutical … 47;tenofovir alafenamide), and Complera (rilpivirine/emtricitabine … from specific drug components. The HIV treatment landscape has … medicines as their top priority. Clinical trials

  • Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan) 31 Mar 2025 11:59 GMT

    doctor about the condition. “Despite using over-the-counter medications and prescription treatments … a medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY) used to treat HIVPharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA

  • Gilead Sciences - Leader In HIV Medicines 14 Mar 2025 20:21 GMT

    Complera/Eviplera, Symtuza, Truvada, Stribild, and Sunlenca products for the treatmentHIV medication Biktarvy should be up 10.3%, sales of older, legacy HIV drugstrials for Lenacapavir, a biannual shot to prevent HIV … - Undiscovered Biotechnology Stock …

  • HIV Treatment Information for Pregnant Women 30 Jan 2025 20:04 GMT

    … on COMPLERA prior to pregnancy and are virologically suppressed (HIV-1 … of rilpivirine, a component of COMPLERA, were observed during pregnancy, … available for the approved treatment dose of 600 mg … available for the approved treatment dose of 600 mg …

  • 3 Biotech Stocks Revolutionizing Healthcare 30 Jan 2025 16:04 GMT

    … in fundamentally stable biotech stocks, Vertex Pharmaceuticals Incorporated (VRTX), … demand for personalized medicine and breakthroughs in … 50 novel drugs by the U.S. FDA in … Complera/ Eviplera, Stribild, Sunlencs for the treatment of HIV/AIDS, …

  • Gilead to End Free Access to Four HIV Meds Via Patient Assistance Programs 09 Jan 2025 03:02 GMT

    … Gilead’s other blockbuster HIV drugs, such as Biktarvy and … provide free medication for Truvada, Emtriva, Tybost and Complera,” stated … four medications. In addition to being used as HIV treatment, Truvada … and Descovy are daily pills, and Apretude is a …

Satisfied with the content?

Continue to create your account.